Hypothesis

Intermittent exposure to β‑hydroxybutyrate (BHB) via time‑restricted ketogenic feeding will produce sustained HDAC inhibition‑driven FOXO3 activation without triggering the senescent cell accumulation seen with continuous ketogenic diets, thereby extending healthspan in middle‑aged mammals.

Mechanistic Rationale

Continuous BHB elevation (as achieved by long‑term ketogenic diets) maintains HDAC inhibition but also depletes cytosolic NAD⁺ and sustains mTORC1 activity, creating a milieu that favors senescence‑associated secretory phenotype (SASP) induction in tissues such as heart and kidney【4†L1-L3】. In contrast, pulsed BHB spikes (e.g., 12‑h fasting/12‑h ketogenic windows) generate transient HDAC inhibition sufficient to increase histone acetylation at FOXO3 promoters and promote its nuclear translocation, while allowing NAD⁺ recovery between pulses【2†L1-L4】. This oscillatory pattern can activate autophagy‑lysosomal pathways and upregulate senolytic mediators (e.g., FOXO3‑dependent BIM and PUMA) that clear nascent senescent cells before they establish a stable SASP【5†L1-L2】. Thus, the timing of BHB exposure, not just its concentration, determines whether HDAC inhibition translates into beneficial FOXO3 signaling or deleterious senescence accrual.

Testable Predictions

1. Middle‑aged mice receiving an intermittent ketogenic regimen (2 days ketogenic diet followed by 5 days standard chow) will show:
   • Increased H3K9ac and FOXO3 target gene expression (e.g., Sod2, Catalase) comparable to continuous ketogenic diet groups.
   • Lower senescent cell burden (p16^Ink4a^+ or SA‑β‑gal^+ cells) in heart and kidney tissues than continuous ketogenic diet controls.
   • Improved functional healthspan metrics (grip strength, treadmill endurance, hippocampal‑dependent memory) relative to both continuous ketogenic diet and standard chow groups.
2. Pharmacologic HDAC inhibition (using a class‑I selective inhibitor at concentrations matching BHB‑mediated inhibition) without BHB will reproduce the FOXO3 activation but will not reduce senescent cell accumulation unless combined with an intermittent fasting schedule that restores NAD⁺ levels.
3. In humans, a 4‑week crossover trial comparing time‑restricted ketogenic feeding (e.g., 10‑hour ketogenic window daily) to an isocaloric continuous ketogenic diet will reveal:
   • Higher circulating BHB peaks (>4 mM) during the ketogenic window with rapid return to baseline.
   • Increased peripheral blood mononuclear cell FOXO3 acetylation and downstream antioxidant gene expression.
   • No rise in circulating senescence‑associated cytokines (IL‑6, IL‑1RA, GDF‑15) compared with the continuous ketogenic arm.

Experimental Design

• Animal study: Use C57BL/6J mice aged 12 months (mid‑life). Four groups (n=30 per arm): (1) standard chow ad libitum, (2) continuous ketogenic diet (90 % fat, 10 % protein) ad libitum, (3) intermittent ketogenic diet (2 days ketogenic/5 days chow repeating), (4) intermittent ketogenic diet + NAD⁺ booster (nicotinamide riboside) to test NAD⁺ dependence. Measure BHB levels (tail bleed), histone acetylation (Western blot of H3K9ac), FOXO3 nuclear localization (immunofluorescence), senescence markers (p16^Ink4a^ immunohistochemistry, SA‑β‑gal), NAD⁺/NADH ratio, and healthspan assays over 6 months.
• Human pilot: Randomized crossover, 20 volunteers aged 45‑60, BMI 25‑30, each arm 4 weeks with 2‑week washout. Continuous ketogenic diet (70 % fat) vs time‑restricted ketogenic feeding (10‑hour ketogenic window, same macronutrients). Collect fasting and post‑meal BHB, PBMC acetyl‑H3K9, FOXO3 target mRNA, SASP plasma panel, and functional tests (6‑minute walk, cognitive battery).

Potential Outcomes and Falsifiability

• If intermittent BHB fails to reduce senescent cell markers despite FOXO3 activation, the hypothesis that timing decouples benefits from senescence is falsified.
• If continuous ketogenic diet does not increase senescence in our mouse model (perhaps due to strain‑specific differences), the observed contradiction in the literature would need re‑examination, challenging the premise that long‑term ketogenic diets uniformly promote senescence.
• Conversely, observing improved healthspan with intermittent BHB without FOXO3 activation would suggest alternative mechanisms (e.g., ketone‑mediated GPR109A signaling) are primary, refuting the HDAC‑FOXO3 centrality claim.